Muen (Guangzhou) Biotechnology Co., Ltd.
PrivateLast Round
C+轮
Jul 1, 2024
Total Funding Raised
$57.82M
Company Overview
Muen (Guangzhou) Biotechnology Co., Ltd. operates in Healthcare & Life Sciences and is based in Guangzhou. Its latest recorded funding round was a C+轮 round in July 2024.
Muen (Guangzhou) Biotechnology Co., Ltd. is a biotechnology company that develops and markets microbial products for the biopharmaceutical and agricultural sectors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Muen (Guangzhou) Biotechnology Co., Ltd. Comparables
Compare Muen (Guangzhou) Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shenzhen 01 Life Technology Co., Ltd. | 82% | |
| Xbiome | 81% | |
| 微康益生菌（苏州）股份有限公司 | 78% |
For institutional investors. Book with your work email.
Muen (Guangzhou) Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| C+轮 | Jul 1, 2024 | ||||
| Strategic | Mar 4, 2022 | ||||
| Series C | Dec 31, 2021 | ||||
| Series B Extension | Jun 23, 2021 | ||||
| Series B | Feb 18, 2020 | ||||
Pre Seed | Jun 14, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Muen (Guangzhou) Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longmen Capital | Series B Extension |
| Highlight Capital | Pre Seed |
| Tasly Capital | Series B Extension |
| SDIC Venture Capital | Series B Extension, Series C |
| Guangzhou Yuexiu Industrial Investment Fund Management | Pre Seed, Series B, Angel |
| HongShan Capital Group (HSG) | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2024
Raised $42M in a C+ round.
- Mar 4, 2022
Completed a strategic funding round.
For institutional investors. Book with your work email.
Muen (Guangzhou) Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Muen (Guangzhou) Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Muen (Guangzhou) Biotechnology Co., Ltd. a public or private company?
Muen (Guangzhou) Biotechnology Co., Ltd. is a private company.
What is the current stock price of Muen (Guangzhou) Biotechnology Co., Ltd.?
Muen (Guangzhou) Biotechnology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Muen (Guangzhou) Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Muen (Guangzhou) Biotechnology Co., Ltd. worth (valuation)?
Valuation information for Muen (Guangzhou) Biotechnology Co., Ltd. is not publicly available.
Can I buy Muen (Guangzhou) Biotechnology Co., Ltd. stock?
Muen (Guangzhou) Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Muen (Guangzhou) Biotechnology Co., Ltd.'s last funding round?
Muen (Guangzhou) Biotechnology Co., Ltd.'s most recent funding round was C+轮 on July 1, 2024.
Who are the main investors in Muen (Guangzhou) Biotechnology Co., Ltd.?
Key investors in Muen (Guangzhou) Biotechnology Co., Ltd. include Highlight Capital, SDIC Venture Capital, Guangzhou Yuexiu Industrial Investment Fund Management, HongShan Capital Group (HSG).
Will Muen (Guangzhou) Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Muen (Guangzhou) Biotechnology Co., Ltd..
How can I track Muen (Guangzhou) Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Muen (Guangzhou) Biotechnology Co., Ltd.'s shares on secondary markets.